Jun. 26 at 8:06 PM
$IKT
Phase 3 Risvo
https://www.globenewswire.com/news-release/2025/05/21/3085719/0/en/ABLi-Therapeutics-Announces-Details-of-the-End-of-Phase-2-Meeting-with-FDA-for-Evaluation-of-Risvodetinib-as-a-Treatment-for-Parkinson-s-Disease.html